A randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP)
暂无分享,去创建一个
S. Hollerbach | R. Hofheinz | J. Hartmann | G. Schuch | J. Stoehlmacher | S. Al-Batran | S. Probst | E. Jäger | N. Homann | H. Schmalenberg